TAMING AFRICA'S LEADING DISEASE

A A

At a recent conference in Nairobi, the World Health Organisation came under severe attack, especially because of a general suspicion by participants that its policies are tailored to benefit "big guys" — giant pharmaceutical firms — and because the health body had asked 18 companies across the world to stop manufacturing monotherapies — drugs based on artemisinin alone.
The East African